Operating Lease, Liability in USD of Omega Therapeutics, Inc. from Q1 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Omega Therapeutics, Inc. quarterly Operating Lease, Liability history and change rate from Q1 2022 to Q3 2024.
Omega Therapeutics, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2024 was $113M, a 1.08% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Omega Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$113M	+$1.21M	+1.08%	30 Sep 2024	10-Q	14 Nov 2024
Q2 2024	$110M	+$11.4M	+11.5%	30 Jun 2024	10-Q	06 Aug 2024
Q1 2024	$110M	+$107M	+4681%	31 Mar 2024	10-Q	06 May 2024
Q4 2023	$110M	+$107M	+4043%	31 Dec 2023	10-K	28 Mar 2024
Q3 2023	$111M	+$108M	+3626%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$98.7M	+$95.2M	+2728%	30 Jun 2023	10-Q	03 Aug 2023
Q1 2023	$2.3M	-$2.01M	-46.6%	31 Mar 2023	10-Q	04 May 2023
Q4 2022	$2.64M			31 Dec 2022	10-K	01 Mar 2023
Q3 2022	$2.99M			30 Sep 2022	10-Q	08 Nov 2022
Q2 2022	$3.49M			30 Jun 2022	10-Q	04 Aug 2022
Q1 2022	$4.3M			31 Mar 2022	10-Q	04 May 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.